Dementia screening has been investigated, showing only a mild cerebellar atrophy (Figure 1A; Supplementary Figures 1A–D) and morphologic changes due to global loss of brain volume via MRI (Figure 1B), albeit without a prove of ß-amyloid-or tau pathology within cerebrospinal fluid analysis. The gene discussed is MAPT; the disease is Cerebellar atrophy.